Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shea T Meyer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancers|March 6, 2021
Targeting SHIP1 and SHIP2 in CancerChiara Pedicone, Shea T Meyer, John D Chisholm, et al.
Molecules (Basel, Switzerland)|December 11, 2022
<i>N1</i>-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor AgentsSandra Fernandes, Shea T Meyer, Jigisha P Shah, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Structure-Activity Studies on Bis-Sulfonamide SHIP1 ActivatorsShea T Meyer, Sandra Fernandes, Robert E Anderson, et al.
Frontiers in Immunology|May 23, 2022
LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 AgonismRaki Sudan, Sandra Fernandes, Neetu Srivastava, et al.
Iscience|April 25, 2022
Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microgliaChiara Pedicone, Sandra Fernandes, Alessandro Matera, et al.
Molecular Medicine (Cambridge, Mass.)|October 22, 2025
SHIPi improves hematologic recovery after chemotherapySandra Fernandes, Chiara Pedicone, Otto M Dungan, et al.
Iscience|February 23, 2023
Obesity control by SHIP inhibition requires pan-paralog inhibition and an intact eosinophil compartmentSandra Fernandes, Neetu Srivastava, Chiara Pedicone, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancers|March 6, 2021
Targeting SHIP1 and SHIP2 in CancerChiara Pedicone, Shea T Meyer, John D Chisholm, et al.
Molecules (Basel, Switzerland)|December 11, 2022
<i>N1</i>-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor AgentsSandra Fernandes, Shea T Meyer, Jigisha P Shah, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Structure-Activity Studies on Bis-Sulfonamide SHIP1 ActivatorsShea T Meyer, Sandra Fernandes, Robert E Anderson, et al.
Frontiers in Immunology|May 23, 2022
LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 AgonismRaki Sudan, Sandra Fernandes, Neetu Srivastava, et al.
Iscience|April 25, 2022
Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microgliaChiara Pedicone, Sandra Fernandes, Alessandro Matera, et al.
Molecular Medicine (Cambridge, Mass.)|October 22, 2025
SHIPi improves hematologic recovery after chemotherapySandra Fernandes, Chiara Pedicone, Otto M Dungan, et al.
Iscience|February 23, 2023
Obesity control by SHIP inhibition requires pan-paralog inhibition and an intact eosinophil compartmentSandra Fernandes, Neetu Srivastava, Chiara Pedicone, et al.
Pageof 1